• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Provectus Biopharmaceuticals, Inc. (PVCT)

    -NYSE MKT
    0.88 Down 0.04(4.45%) Mar 2, 4:01PM EST
    Add to Portfolio
    Prev Close:0.92
    Open:0.92
    Bid:0.82 x 1000
    Ask:0.94 x 1000
    1y Target Est:3.50
    Beta:1.7
    Next Earnings Date:N/A
    Day's Range:0.87 - 0.92
    52wk Range:0.30 - 3.75
    Volume:339,794
    Avg Vol (3m):387,545
    Market Cap:158.66M
    P/E (ttm):N/A
    EPS (ttm):-0.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PVCT

    Comparison

    Symbol% ChgMkt Cap
    PVCTDown 4.45%158.66M
    QLTIDown 1.49%202.69M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Provectus Biopharmaceuticals, Inc., a development-stage biopharmaceutical company, is engaged in developing pharmaceuticals for oncology and dermatology indications. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback